Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 715 (USA) (Dr. Moreau)
· consented 2013-07-06
Adverse events
6
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
moderate
assessed
2026-08-18
Moderate CONFUSIONAL STATE — outcome: RECOVERED/RESOLVED; onset 2013-07-08 (study day 3.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate DIZZINESS — outcome: RECOVERED/RESOLVED; onset 2013-07-08 (study day 3.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate HYPERHIDROSIS — outcome: RECOVERED/RESOLVED; onset 2013-07-08 (study day 3.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate PALPITATIONS — outcome: RECOVERED/RESOLVED; onset 2013-07-08 (study day 3.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate SINUS BRADYCARDIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-13 (study day 8.0); relationship: NONE
moderate
assessed
2026-08-18
Moderate SINUS BRADYCARDIA — outcome: RECOVERED/RESOLVED; onset 2013-07-13 (study day 8.0); relationship: NONE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.